These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11775405)

  • 1. [We, the Italian physicians, and statins].
    Bobbio M
    Ital Heart J Suppl; 2001 Nov; 2(11):1149-54. PubMed ID: 11775405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The withdrawal of Baycol (cerivastatin).
    Griffin JP
    Adverse Drug React Toxicol Rev; 2001 Dec; 20(4):177-80. PubMed ID: 11770168
    [No Abstract]   [Full Text] [Related]  

  • 3. [Myopathy with rhabdomyolysis as an adverse effect of simultaneous treatment with cerivastatin and gemfibrozil].
    Huić M; Anić B; Cikes N; Bosnić D; Sentić M; Markeljević J; Mayer M; Pazanin L
    Lijec Vjesn; 2002; 124(3-4):73-6. PubMed ID: 18956824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhabdomyolysis associated with hydroxymethylglutaryl-coenzyme A reductase inhibitors.
    Jamal SM; Eisenberg MJ; Christopoulos S
    Am Heart J; 2004 Jun; 147(6):956-65. PubMed ID: 15199341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cerivastatin and the PRINCESS study: reflexions after 1 year].
    Manfredi C; Macrì R; Bartoli M
    Ital Heart J Suppl; 2003 Feb; 4(2):125-7. PubMed ID: 12762262
    [No Abstract]   [Full Text] [Related]  

  • 6. Experts confirm statins' safety but advise caution with certain patients.
    Levenson D
    Rep Med Guidel Outcomes Res; 2002 Jul; 13(13):1-2, 5. PubMed ID: 12515256
    [No Abstract]   [Full Text] [Related]  

  • 7. Rhabdomyolysis from the combination of a statin and gemfibrozil: an uncommon but serious adverse reaction.
    Kind AH; Zakowski LJ; McBride PE
    WMJ; 2002; 101(7):53-6. PubMed ID: 12426921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Withdrawal of cerivastatin revealed a flaw of post-marketing surveillance system in the United States].
    Saito M; Hirata-Koizumi M; Miyake S; Hasegawa R
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2005; (123):41-5. PubMed ID: 16541751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cerivastatin withdrawal crisis: a "post-mortem" analysis.
    Maggini M; Raschetti R; Traversa G; Bianchi C; Caffari B; Da Cas R; Panei P
    Health Policy; 2004 Aug; 69(2):151-7. PubMed ID: 15212862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Safety profile of statins].
    Prieto JC
    Rev Med Chil; 2001 Nov; 129(11):1237-40. PubMed ID: 11836874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [After recall of cerivastatin. How safe are statins in reality? (interview by Dr. Dirk Einecke)].
    Schwandt P
    MMW Fortschr Med; 2001 Aug; 143(33-34):12. PubMed ID: 11561452
    [No Abstract]   [Full Text] [Related]  

  • 12. The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: a nested case-control analysis.
    Koro CE; Sowell MO; Stender M; Qizilbash N
    Clin Ther; 2008 Mar; 30(3):535-42. PubMed ID: 18405791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High rates of adverse effects and patient unawareness of withdrawn lipid-lowering drug combination in a public hospital clinic.
    Schiff GD; Keehr LM; Sai TT; Bult J
    Pharmacoepidemiol Drug Saf; 2002 Dec; 11(8):643-5. PubMed ID: 12512238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Statins in practice of the vascular surgeon and cardiologist].
    Pokrovskiĭ AV; Suntsov DS
    Angiol Sosud Khir; 2009; 15(2):123-7. PubMed ID: 19806952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rhabdomyolysis and anuric kidney failure induced by the treatment with a gemfibrozil-cerivastatin combination].
    Sirvent AE; Cabezuelo JB; Enríquez R; Amorós F; González C; Reyes A
    Nefrologia; 2001; 21(5):497-500. PubMed ID: 11795020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of statins on renal function.
    Agarwal R
    Am J Cardiol; 2006 Mar; 97(5):748-55. PubMed ID: 16490450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Side effects of statins--prevalence, relevance, consequences.
    Sinzinger H
    Wien Klin Wochenschr; 2002 Nov; 114(21-22):887-8. PubMed ID: 12528318
    [No Abstract]   [Full Text] [Related]  

  • 18. [Statines for all or individualized lipid lowering therapy?].
    Parhofer K
    MMW Fortschr Med; 2009 Apr; 151(14):100, 102-4; quiz 105. PubMed ID: 19504849
    [No Abstract]   [Full Text] [Related]  

  • 19. Rhabdomyolysis associated with cerivastatin plus gemfibrozil combined regimen.
    Marsà Carretero M; Alos Manrique C; Valles Callol JA
    Br J Gen Pract; 2002 Mar; 52(476):235-6. PubMed ID: 12030671
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of the synergistic adverse effects of concomitant therapy with statins and fibrates on rhabdomyolysis.
    Matzno S; Tazuya-Murayama K; Tanaka H; Yasuda S; Mishima M; Uchida T; Nakabayashi T; Matsuyama K
    J Pharm Pharmacol; 2003 Jun; 55(6):795-802. PubMed ID: 12841940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.